コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 )In-octreotide it was 78.2%; specificity was not available).
2 eption of families in which DNA analysis was not available).
3 ents per person-year (n = 17, patient 1 data not available).
4 tent tags working in bright environments are not available.
5 et regimens, but long-term outcomes data are not available.
6 es, or when information on all predictors is not available.
7 ical treatments for infected individuals are not available.
8 but an effective antiviral therapy is still not available.
9 ermore, human B. bronchiseptica vaccines are not available.
10 ncome countries where surgical management is not available.
11 tionally involved since phase information is not available.
12 additional vessels from the organ donor are not available.
13 ndard Digene Hybrid Capture 2 (HC2) test are not available.
14 ct feedback from participating hospitals was not available.
15 vaccines are desperately required but still not available.
16 An effective EBV vaccine is not available.
17 he study of interplay of these mechanisms is not available.
18 une cells for which unique Abs are currently not available.
19 drial homeostasis in APTX-deficient cells is not available.
20 utic treatment for hearing loss is currently not available.
21 oneously estimated if strand information was not available.
22 limited and curative treatment regimens are not available.
23 matrices for external calibration curves are not available.
24 , yet Salmonella-specific antibacterials are not available.
25 s an alternative, especially when bismuth is not available.
26 in countries where the reverse cold chain is not available.
27 early in the season when coupled models were not available.
28 Age-specific data for some harms were not available.
29 h metastatic renal cell carcinoma (mRCC) are not available.
30 udo-replicates when technical replicates are not available.
31 s, SLE disease activity, and medications was not available.
32 ning tool for ALVD in the doctor's office is not available.
33 urvival following DSB induction when H2AX is not available.
34 Information on the severity of CP was not available.
35 being a key indicator of reproducibility, is not available.
36 and nesting resources when apple flowers are not available.
37 190 mg/dl), overall prevalence estimates are not available.
38 wever, effective and safe vaccines are still not available.
39 rate estimation of AAA rupture risk is still not available.
40 and policy efforts where biological data are not available.
41 where blood pressure-lowering medicines were not available.
42 ta for peak expiratory flow variability were not available.
43 data with direct-acting antiviral agents are not available.
44 CR is delayed, shows negative results, or is not available.
45 Effective chemotherapy is not available.
46 uts because individual-participant data were not available.
47 mains for which ready-made formal models are not available.
48 a (SaB) animal models, but clinical data are not available.
49 rural areas in China during this period are not available.
50 exon units in cancer and normal tissues are not available.
51 rrogate tumor biopsy when Rb tumor tissue is not available.
52 m hematopoietic stem cell transplantation is not available.
53 toxicants and carcinogens in wastewater are not available.
54 tudies, for most of them this information is not available.
55 a required to fully test the hypothesis were not available.
56 mitigate the adverse effects of drought are not available.
57 a working diagnosis of IPF if lung tissue is not available.
58 that physiologically relevant tubulins were not available.
59 cine to prevent C. trachomatis infections is not available.
60 sed vaccines or suitable antiviral drugs are not available.
61 Up to now, approved treatment options are not available.
62 d only for interventions for which RCTs were not available.
63 nvasive biomarkers for PSC, CCA, and HCC are not available.
64 e decision making when immediate feedback is not available.
65 ecially where electronic medical records are not available.
66 ortical pathways when PER-POR interaction is not available.
67 s included in the risk prediction models was not available.
68 especially when high-quality antibodies are not available.
69 one country endomysial antibodies (EMA) were not available.
70 oorly understood and targeted treatments are not available.
71 tion calling method when normal controls are not available.
72 for metazoa that undergo DNA elimination are not available.
73 or semi-automated variant interpretation are not available.
74 of studies for which the required data were not available.
75 res external allele frequency data which may not available.
76 s, especially when skilled microscopists are not available.
77 ress, especially if the protein structure is not available.
78 easy scheme for their in vitro synthesis is not available.
79 lters endogenous protein levels is currently not available.
80 sity or period of time (season) is currently not available.
81 a good alternative when higher resolution is not available.
82 ZER Septal Occluder in clinical practice are not available.
83 ody test result if HCV RNA measurements were not available.
84 ted for CJD, in part because an easy test is not available.
85 tudies performed, specific markers are still not available.
86 the blood pool; histologic confirmation was not available.
87 t opinion because rigorous clinical data are not available.
88 Drug data for treatment of depression were not available.
89 whole-slide scanning microscopy systems are not available.
90 n is viable when biomonitoring organisms are not available.
91 N sources in the residential catchments are not available.
92 restricted because fresh-frozen tissues are not available.
93 he gene expression profile of these cells is not available.
94 diagnosis, and a management plan if CT were not available.
95 hen glucose and other fermentable sugars are not available.
96 gle individual when mates or pollinators are not available.
97 ure for conventional wastewater treatment is not available.
98 2 degrees C above preindustrial levels were not available.
99 candidates appropriate for PPI cessation is not available.
100 agents that directly target mutant KRAS are not available.
101 useful when a suitable structure template is not available.
102 iteria, and specific biochemical markers are not available.
103 to include data from RCTs for which IPD was not available.
104 ries where newer, expensive combinations are not available.
105 lines based on patient-reported outcomes are not available.
106 rgy expenditure when indirect calorimetry is not available.
107 italization and death after HHC discharge is not available.
108 nome-wide evaluation of these predictions is not available.
109 Data on postnatal factors were not available.
110 different brain lesions causing epilepsy is not available.
111 ry (AKI), targeted preventive strategies are not available.
112 ructures of filament-associated troponin are not available.
113 h as a pathologic entity are currently still not available.
114 scintigraphy, especially when PET imaging is not available.
115 elihood evaluation when exact techniques are not available.
116 Data on falls and syncope were not available.
117 f the functional features of fusion genes is not available.
118 tus of minipigs upon EPI induction are still not available.
119 determined by PCR, or microscopy if PCR was not available.
120 ective treatment and prevention measures are not available.
121 elatively brief, and patient-level data were not available.
122 for which a commercial vaccine for humans is not available.
123 In 4 patients the SMN2 copy number was not available.
124 -matched donors, but when a matched donor is not available, a haploidentical or mismatched unrelated
125 ination or laboratory-confirmed infection is not available, Advisory Committee on Immunization Practi
126 8.3 [95% CI, 4.4-15.9]; AFE, 88%), PIV (OR, not available; AFE, approximately 100%), HMPV (OR, 9.8 [
127 9.8 [95% CI, 2.3-41.0]; AFE, 90%), AdV (OR, not available; AFE, approximately 100%), RV (OR, 7.1 [95
128 ods for use when cell-type specific DMRs are not available, allowing scientists to estimate putative
129 person delivering the intervention was often not available, although 78% (n = 49) of reviews mentione
130 unds experimentally determined L-values were not available and had to be measured using gas chromatog
131 ogic toolbox in cases in which real data are not available and in cases in which traditional epidemio
132 the chemo-resistivity of the cancer cells is not available and it currently takes weeks to months to
133 Commercial inhibitors for HtrA proteases are not available and physiologic HtrA inhibitors are unknow
134 s where integrated multidisciplinary care is not available and resources are lacking at present.
135 in recent years, but prospective studies are not available and the complication profile is poorly und
136 ers, but alternative approved treatments are not available, and in the case of HMA failure, there are
138 but their potent and specific inhibitors are not available, and strategies for inhibitor development
139 models to predict risk for complications are not available, and the effect of treatment on risk is un
140 a glucose level and HbA1c concentration were not available, and the glycemic control status was evalu
141 against the parasite that causes malaria is not available, antimalarial drug treatments are critical
145 g spatial light modulators, such methods are not available at all lengthscales and wavelengths of ill
147 Data on private benefits from land use are not available at similar scales and resolutions, resulti
152 lues from the literature, many of which were not available at the time that the mysteries emerged, it
157 al data containing structural restraints are not available, but one still wants to obtain knowledge a
159 an PFS was 13.3 months (90% CI, 12 months to not available/computable [NA]) for gPALB2 and 6.3 months
160 , placebo-controlled food challenge data are not available, data from widely used open food challenge
161 rinciples of thermodynamics and kinetics are not available, despite the critical role that such preci
162 sorders associated with de novo mutations is not available, despite their relatively high incidence(3
163 fibrotic therapeutic solutions, however, are not available due to the poorly defined characteristics
164 ion on the internal OC exposure in humans is not available, due to the lack of appropriate biomarkers
166 hin ice films, providing a mechanism that is not available during the growth of strained films in oth
167 This study provides molecular information not available earlier, including exploration of the pote
168 a complete-case analysis in which data were not available for 23 patients in the intervention group
176 es, invasive mechanical ventilation is often not available for children at risk of death from respira
177 noscale MOFs, rapid and flexible methods are not available for continuous, one-pot synthesis and post
180 participants, and that longitudinal data are not available for long-term follow-up of individuals.
185 of choice; however, these genetic tools are not available for most organisms and alternative labelin
186 , and current disease severity criteria were not available for patients in the 2003-to-2007 cohort.
187 WCR diets contain corn root powder, which is not available for purchase, thereby limiting the practic
189 Specifically, original numerical data are not available for the majority of the graphs presented i
194 the rate of future cognitive decline that is not available from a dichotomous positive/negative categ
195 complex and contraction mechanism, which is not available from baseplate structures of the (DNA-cont
196 arch data can provide a breadth of knowledge not available from individual sources and can provide co
199 mical insights at the single organelle level not available from organelle population level studies.
201 genes and swine virus genomic sequences are not available from the exposure source, future cases may
202 itionally each modality provides information not available from the other providing both a molecular
203 cular line; and if a baseline measurement is not available, hepatomegaly can be defined as greater th
205 ined and unique loci of the yeast genome are not available, hindering studies of DSB repair in differ
211 h, particularly where clinical specimens are not available in amounts amenable to standard workflows.
214 eeting abstracts, "gray" literature, studies not available in English, and studies with non-original
217 ystal structure of full-length BM3 enzyme is not available in its monomeric or catalytically active d
218 istinguish clinically, and rapid testing was not available in many Ebola Treatment Units (ETUs), guid
222 to political and regulatory barriers, it is not available in many settings around the world, which l
223 systems require costly or bespoke materials not available in most countries, where breeders need too
230 increased cocaine seeking when the drug was not available in rats trained to discriminate its presen
233 nmeasured confounding causes of microcephaly not available in routinely collected surveillance data.
235 te when expression data for causal genes are not available in the causal tissue by leveraging express
238 nography (USON), the screening gold standard not available in the more recent NHANES, and the noninva
241 D and the resulting reducing equivalents are not available in the outermost few nanometers of clay su
242 ble studies; if the required information was not available in the published report, we requested raw
245 ing popularity, MTL algorithms are currently not available in the widely used software environment R,
246 where electrophysiology subspecialty care is not available leads to outcomes that are noninferior to
249 unknown and antemortem diagnostic tests are not available, neuropathology studies suggest a pathogen
250 e approved drugs and vaccines are limited or not available, new options for COVID-19 treatment and pr
253 ific triggers of manic symptoms, studies are not available on the effectiveness of targeted intervent
258 treatment, because new KRAS(G12C) is either not available or exists in its inactive, drug-sensitive
260 -59 days) with suspected sepsis is sometimes not available or feasible in countries with high neonata
261 toring where reference-standard equipment is not available or feasible, and that they may be useful i
262 /HLA-matched family donor HSCT or HSC-GT are not available or have failed, ERT can be continued or re
263 l therapy, especially when fecal samples are not available or molecular diagnostic tests are not acce
266 When prior computed tomography imaging was not available, our model outperformed all six radiologis
267 back control of cardiac electrical activity, not available previously with pharmacological and electr
268 es of cancer cell lines to perturbations are not available, resulting in a critical knowledge gap.
271 s where stable, transform-limited pulses are not available, such as X-ray free-electron lasers which
272 ere spaceflight-specific data/equations were not available, terrestrial data/equations were used.
273 t candidates when recombination map data are not available, the [Formula: see text] and [Formula: see
275 ontrol at the liquid/solid interface that is not available through conventional CVD synthesis at the
276 the possibility that complete continua were not available through our comprehensive search of the pu
277 lifetime-risk data for implant revision are not available to aid patient decision making, which is a
279 on, similar mathematical tools are currently not available to describe TC formation in a universal ma
280 ality performance and outcome indicators are not available to guide patient choice, these policies co
281 ttings with sophisticated intensive care, is not available to infants in many sub-Saharan African cou
282 ry pathway to extremes in body size that are not available to lineages that must feed on one prey at
283 suitable questionnaire in German language is not available to monitor the progression and evaluate th
284 he high volume of sequence homologs that are not available to most of the non-humongous protein targe
287 generally applicable methodologies are still not available to the computational and medicinal chemist
288 nzymes or deletion of competing pathways are not available to the metabolic engineer; instead, fatty
289 nt for rheumatic mitral regurgitation but is not available to the vast majority of patients in endemi
292 aphically independent cohorts(7,8) that were not available to us when we trained the algorithms.
293 Whenever suitable template structures are not available, usage of fragment-based protein structure
295 ication runs even when a native structure is not available, visualizing the contact coverage and simi